Email Page Print Page

SEC Filings and Financial Information

NASDAQBDSI
FormDescriptionDateFormat
10-QQuarterly report which provides a continuing view of a company's financial positionNov 5, 2014View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
10-QQuarterly report which provides a continuing view of a company's financial positionAug 7, 2014View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
10-QQuarterly report which provides a continuing view of a company's financial positionMay 9, 2014View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
Top News
Nov 16, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that Dr. Mark A. Sirgo, Vice...

Nov 9, 2017

BioDelivery Sciences International, Inc. (BDSI) today reported financial results for the three and nine months ended September 30, 2017, and provided an update on recent business highlights and...

Oct 30, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it will report its third quarter 2017 financial results and host a conference call and webcast at 4:30 PM Eastern Time on...

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com